Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report)’s stock price traded up 17.7% during mid-day trading on Monday . The company traded as high as $88.24 and last traded at $88.24. 4,000 shares were traded during mid-day trading, an increase of 725% from the average session volume of 485 shares. The stock had previously closed at $75.00.
Pharma Mar Stock Performance
The company’s fifty day moving average price is $79.78 and its two-hundred day moving average price is $60.89. The company has a current ratio of 2.55, a quick ratio of 2.01 and a debt-to-equity ratio of 0.14.
About Pharma Mar
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Featured Articles
- Five stocks we like better than Pharma Mar
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 Steel Stocks Soaring After Tariff Announcements
- How to Use the MarketBeat Dividend Calculator
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
